Board

Mr. Gill Eapen MS, MBA, CFA

Over 2 decades of experience in finance, economics, planning and management. Over 10 years experience in fund management. Previous employers include Pfizer, HP, Deloitte & ABB. Consulting clients in various industries including pharmaceuticals, high technology, aerospace, manufacturing and consumer goods. MBA - University of Chicago, MS - Northwestern University, B. Tech - Indian Institute of Technology. CFA Charter holder. Detailed Background at (Gill Eapen)

Dr. Craig Saxton M.D. Ph.D.

Over 3 decades of experience in guiding large scale Research and Development. Retired Executive Vice President, Pfizer. Member of the board of directors of Tularik , Neurogen and Veritas Medicine. Graduated in medicine from the University of Leeds in 1965. Pursued research in Cardiovascular disease and applied physiology from 1966 until joining Pfizer in 1976.

 

Site Map | Printable View | © 2008 - 2024 Decision Options, LLC | Powered by mojoPortal | HTML 5 | CSS | Design by mitchinson
Share This Using Popular Bookmarking Services